Insiders · Profile

Keller Peter

Chief Business Officer at Cartesian Therapeutics. Filing since 19 Dec 2016. CIK 0001676904

Company
Date
Role
Action
Shares
Amount
Of holding
27 Jun 2017
Chief Business Officer
Sold, plan not stated
4,595
$88.68K
91.9%
19 Dec 2016
Chief Business Officer
Sold, plan not stated
4,723
$87.75K
92.1%
2 decisions on file.